Khairunnisa B, Azizah Nasution


Objectives: to assess the pharmacists' perception about their roles in tuberculosis (TB) control program in Medan, Indonesia.

Methods: A cross-sectional study was conducted to assess the pharmacists' perception about their roles in TB control program in Medan, Indonesia using a validated questionnaire. The pharmacists involved in this study (n=117) were asked to choose answering yes, no or do not know for their perception on their roles in TB control program. The collected data consisted of demographics (gender, age, place of practice, and working experience) and the pharmacists’ perception on their roles in TB control program were organized and analyzed by applying descriptive and Chi-square analyses using Statistical Package for the Social Sciences (SPSS, version 19, Chicago, IL, USA) (p value <0.05 was considered significant).

Results: Mean age of the participants was 38.6 (standard deviation=11.7) years. Most of them (76.1%) were female. Distribution of the participants by place of practice:  pharmacy, 78.6%; hospital, 20.5%. Most of them (63.2%) have heard about directly observed treatment short-course (DOTS) program. More than 90% of them realized that they could play their roles as providers, managers of anti-TB drugs, drug informans, ensurers for adherence to the TB treatment, educators for patients and publics on TB and its treatment. Only 26.5% of them knew that they could also play their role as inventors of early suspected TB in the community.

Conclusion: The study proved that the pharmacists’ roles could be utilized and enhanced to optimize TB control programs in Indonesia.

Keywords: Pharmacists’ role, Tuberculosis, DOTS Program

| PDF |


World Health Organization. Global Tuberculosis Report. Geneva: WHO; 2014.

TB Statistics-Global, Regional, and High Burden. Available from: [Last accessed on 2016 Oct 07].

Mkele G. The role of the pharmacist in TB management. S Afr Pharm J 2010;77(2):18-20.

Nakatani H, Buchmann M. The role of the pharmacist in tuberculosis care and control, Singing Ceremony. WHO FIP Joint Statement; 2011. p. 1-4.

Venkatapraveen A, Rampure MV, Patil N, Shivanad SS, Lakshmi DP. Assessment of clinical pharmacist intervention to improve compliance and health care outcomes of tuberculosis patient. Der Pharm Lett 2012;4(3):931-7.

Nanang MY, Djoko W, Bambang SR, Ika PS. Tuberculosis-related to knowledge, adverse drug reactions, clinical outcome, adherence in tuberculosis patients and pharmacist role, a preliminary survey for pharmacist intervention model development. IJPCR 2016;85 Suppl:517-22.

Thamby SA, Subramani P. Seven-star pharmacist concept of WHO. J Young Pharm 2014;6(2):1.

Bayer R, Wilkinson D. Directly observed therapy for tuberculosis: History of an idea. Lancet 1995;345(8964):1545-8.

Squire SB, Wilkinson D. Strengthening “DOTS” through community care for tuberculosis. BMJ 1997;315(720):1395-6.

Frieden TR, Sbarbaro JA. Promoting adherence to treatment for tuberculosis: The importance of direct observation. Bull World Health Organ 2007;85(5):407-9.

Kementerian Kesehatan Republik Indonesia. Public Private Mix Pengendalian Tuberkulosis di Indonesia 2011-2014. Jakarta: Kementerian Kesehatan Republik Indonesia; 2011b.

Bisht RE, Katiyar AL, Singh RA, Mittal PI. Antibiotic resistance-A global issue of concern. Asian J Pharm Clin Res 2009;2(2):34-9.

Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2014;CD000011.

World Health Organization. 2014. Available from: [Last accessed on 2016 Oct 16].

Bhardwaj AL, Kumar RA, Dabas VI, Alam NI. Assessment and enhancing adherence to treatment regimen in tuberculosis out patients. Int J Pharm Pharm Sci 2012;4(3):517-22.

Siddiqui S, Ali Baig MM, Jaffer S, Raza Ansari SF. Study on prevalence of adverse drug reactions in patients suffering from tuberculosis in a tertiary care hospital. Int J Pharm Pharm Sci 2016;8(8):375-7.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, et al. Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis 2016;63(7):853-67.

Sreeramareddy CT, Qin ZZ, Satyanarayana S, Subbaraman R, Pai M. Delays in diagnosis and treatment of pulmonary tuberculosis in India: A systematic review. Int J Tuberc Lung Dis 2014;18(3):255-66.

About this article







Additional Links

Manuscript Submission


Asian Journal of Pharmaceutical and Clinical Research
Vol 10 Issue 4 April 2017 Page: 256-258

Print ISSN


Online ISSN


Authors & Affiliations

Khairunnisa B

Azizah Nasution

Article Tools

Email this article (Login required)
Email the author (Login required)


  • There are currently no refbacks.